The Centers for Medicare & Medicaid Services announced a 2.48% increase in 2027 Medicare Advantage capitation rates, exceeding initial expectations of 0.09%. The boost amounts to over $13 billion in additional payments and reflects a 4.98% increase when accounting for risk score trends. CMS retained the 2024 risk adjustment model, providing greater rate predictability for insurers. Major healthcare stocks surged on the positive announcement.

Alignment Healthcare (NASDAQ: ALHC) announced a secondary public offering of 13.2 million shares priced at $19.46 per share by an affiliate of General Atlantic. The company will not receive proceeds from the sale. The offering is expected to close on March 4, 2026, with J.P. Morgan serving as underwriter.

The Centers for Medicare & Medicaid Services (CMS) proposed a 2027 Medicare Advantage payment increase of only 0.09%, significantly below Wall Street's expectations of 4-6%. This modest growth announcement triggered sharp declines in major health insurer stocks, with UnitedHealth, Humana, and CVS Health leading the losses. The CMS emphasized program sustainability and payment accuracy through updated risk adjustment models.

Alignment Healthcare, a Medicare Advantage company, has been named to Fortune's 2026 World's Most Admired Companies list in its first year of consideration. The recognition reflects the company's leadership, innovation, and operating ability in the healthcare insurance sector. Alignment achieved this distinction alongside numerous 2025 accolades, including 100% of its members enrolled in 4-star or higher rated plans and recognition as one of Newsweek's World's Most Trustworthy Companies for the third consecutive year.

General Atlantic, a 10% owner of Alignment Healthcare, sold 11.1 million shares for $206.5 million on December 12, 2025, representing a 45.2% reduction in its stake. The sale occurred at $18.57 per share, slightly below the market close of $19.36, following a 74% stock price increase over the prior year. While Alignment Healthcare reported strong Q3 2025 results with 43.5% revenue growth and 31% membership growth, the insider selling and projected Medicare Advantage enrollment decline in 2026 warrant investor caution.

BofA Securities highlighted Cigna's strong potential in commercial health insurance, noting its pharmacy benefit management platform and ability to deliver 10-15% annual EPS growth, while also discussing challenges and opportunities in the healthcare insurance market.

Alignment Healthcare reported strong Q3 2025 financial performance, with revenue of $993.7 million, representing a 43.5% year-over-year increase. The company exceeded its high-end guidance and raised its full-year outlook across key metrics.

Alignment Health Plan partnered with Suvida Healthcare to provide bilingual, culturally harmonized primary care for Medicare-eligible seniors in Maricopa and Pima counties, Arizona, aiming to improve healthcare access for Hispanic communities.

Alignment Health Plan partnered with Suvida Healthcare to provide bilingual primary care for Medicare-eligible seniors in Arizona, focusing on culturally attuned healthcare for Hispanic communities in Maricopa and Pima counties.

Alignment Health Plan partnered with Intermountain Health to launch a new $0-premium, 5-star Medicare Advantage HMO plan in Clark County, Nevada, offering comprehensive benefits for seniors including transportation, caregiver support, and healthy grocery allowances.

BofA Securities highlighted Cigna's strong EPS growth potential and investment in Shields Health Solutions, while expressing cautious views on UnitedHealth and Centene due to potential regulatory and margin challenges.

Alignment Health's CEO John Kao was named 'Founder of the Year' at the 2025 Orange County Executive Forum, recognizing his leadership in building a leading Medicare Advantage organization with strong financial performance and community impact.